Gedeon Richter Stock

Equities

RICHTER

HU0000123096

Pharmaceuticals

Delayed Budapest S.E. 07:48:51 2025-02-06 am EST 5-day change 1st Jan Change
10,290.00 HUF +1.68% Intraday chart for Gedeon Richter +1.18% -1.15%

Valuation: Gedeon Richter

Capitalization 1,842B 4.73B 4.54B 4.26B 3.77B 6.75B 413B 7.51B 51.44B 19.05B 170B 17.72B 17.36B 719B P/E ratio 2024 *
7.97x
P/E ratio 2025 * 6.81x
Enterprise value 1,704B 4.37B 4.2B 3.94B 3.49B 6.25B 382B 6.95B 47.58B 17.62B 157B 16.39B 16.05B 665B EV / Sales 2024 *
1.97x
EV / Sales 2025 * 1.71x
Free-Float
-
Yield 2024 *
5.01%
Yield 2025 * 6.25%
More valuation ratios * Estimated data
Dynamic Chart
GRANATA BIO Corp announced that it has received $15 million in funding from Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt., CooperSurgical, Inc., Amboy Street Ventures Jan. 14 CI
GRANATA BIO Corp announced that it expects to receive funding from Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt., CooperSurgical, Inc., Amboy Street Ventures Dec. 18 CI
Bio-Thera Solutions Receives $10 Million Payment Related to Licensing Deal Nov. 14 MT
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Reports Earnings Results for the Nine Months Ended September 30, 2024 Nov. 12 CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt., Q3 2024 Earnings Call, Nov 12, 2024 Nov. 11
AbbVie, Gedeon Richter Partner to Develop New Treatments for Neuropsychiatric Conditions 24-10-24 MT
AbbVie and Gedeon Richter Announces New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions 24-10-24 CI
Bio-Thera Solutions Enters Up to $110 Million Licensing Deal With Gedeon Richter 24-10-10 MT
Bio-Thera Solutions, Ltd. and Gedeon Richter Plc Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara Biosimilar, for EU Countries, UK, Switzerland and Other Selected Countries 24-10-09 CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Reports Earnings Results for the Half Year Ended June 30, 2024 24-08-06 CI
Hungary's Richter profit jumps 144% on FX gains, keeps 2024 guidance 24-08-06 RE
Hungarian and Czech stock markets rebound, currencies weaken 24-08-06 RE
Tranche Update on Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s Equity Buyback Plan announced on April 4, 2023. 24-08-05 CI
More news
1 day+1.88%
1 week+1.48%
Current month+1.28%
1 month-3.01%
3 months-6.27%
6 months+3.51%
Current year-0.87%
More quotes
1 week
10 120.00
Extreme 10120
10 400.00
1 month
10 120.00
Extreme 10120
10 950.00
Current year
10 120.00
Extreme 10120
10 950.00
1 year
8 550.00
Extreme 8550
11 260.00
3 years
6 310.00
Extreme 6310
11 260.00
5 years
5 200.00
Extreme 5200
11 260.00
10 years
3 656.00
Extreme 3656
11 260.00
More quotes
Director TitleAgeSince
Chief Executive Officer 46 2017-10-31
Director of Finance/CFO 58 2021-12-31
Chief Tech/Sci/R&D Officer 65 -
Manager TitleAgeSince
Chairman 77 2016-12-31
Chairman 89 2024-02-29
Director/Board Member 64 2012-04-25
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.19%+1.48%+6.07%+29.20%4.73B
-0.43%+0.17%+18.09%+96.38%48.15B
+0.43%-1.10%+41.09%+95.75%28.13B
+1.00%+1.15%+54.08% - 21.2B
+2.45%+1.01%+3.28%+57.74%13.29B
+3.12%+5.79%+26.50%+153.86%11.26B
-.--%+0.14% - - 6.79B
-.--%-1.95% - - 5.73B
+1.52%+4.72%+44.16%+45.41%5.33B
+0.85%-4.42%-38.96%-45.42%4.73B
Average +1.08%+0.10%+19.29%+61.85% 14.93B
Weighted average by Cap. +0.63%+0.39%+26.28%+86.49%
See all sector performances

Financials

2024 *2025 *
Net sales 864B 2.22B 2.13B 2B 1.77B 3.17B 194B 3.52B 24.13B 8.93B 79.58B 8.31B 8.14B 337B 950B 2.44B 2.34B 2.2B 1.95B 3.48B 213B 3.87B 26.53B 9.83B 87.51B 9.14B 8.95B 371B
Net income 234B 600M 576M 540M 479M 857M 52.39B 953M 6.53B 2.42B 21.53B 2.25B 2.2B 91.31B 273B 700M 672M 631M 560M 1B 61.18B 1.11B 7.62B 2.82B 25.15B 2.63B 2.57B 107B
Net Debt -138B -355M -340M -319M -283M -507M -30.98B -564M -3.86B -1.43B -12.73B -1.33B -1.3B -53.99B -214B -549M -527M -494M -438M -784M -47.94B -872M -5.97B -2.21B -19.71B -2.06B -2.02B -83.56B
More financial data * Estimated data
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,603
Calendar
More about the company
Date Price Change Volume
25-02-06 10,290.00 Ft +1.68% 50,346
25-02-05 10,120.00 Ft -2.13% 378,885
25-02-04 10,340.00 Ft +0.58% 201,761
25-02-03 10,280.00 Ft +0.98% 225,812
25-01-31 10,180.00 Ft +0.20% 610,886

Delayed Quote Budapest S.E., February 06, 2025 at 04:59 am EST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
surperformance-ratings-light-chart GEDEON-RICHTERMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10,120.00HUF
Average target price
12,103.78HUF
Spread / Average Target
+19.60%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. RICHTER Stock